Advertisement

Topics

Tarveda Announces Presentation and Panel Participation at Upcoming Conferences

08:00 EST 1 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Tarveda Therapeutics, Inc., a clinical-stage biopharmaceutical company discovering and developing Pentarins™ as a new class of potent and selective cancer medicines, today announced that Drew Fromkin, President and Chie...

Other Sources for this Article

MacDougall Biomedical Communications
Chris Erdman, 781-235-3060
chris@macbiocom.com
or
George E. MacDougall, 781-235-3060

NEXT ARTICLE

More From BioPortfolio on "Tarveda Announces Presentation and Panel Participation at Upcoming Conferences"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...